dehaze

dehaze

Gesundheits- und Sozialwesen

The end-to-end solution bringing precision medicine to clinical practice.

Info

dehaze provides data-privacy conform access to high-quality (longitudinal) data (incl. patient reported outcomes, comorbidities and molecular data) to enable personalized medicine. While we initially focus on multiples sclerosis (MS), we have an infrastructure that can be used across all (auto-immune and chronic) diseases.

Branche
Gesundheits- und Sozialwesen
Größe
2–10 Beschäftigte
Hauptsitz
Munich
Art
Privatunternehmen
Gegründet
2023

Orte

Beschäftigte von dehaze

Updates

  • Unternehmensseite von dehaze anzeigen, Grafik

    252 Follower:innen

    Your voice counts. Shape the HealthPod app to manage your chronic disease and overcome the struggles of a reactive and fragmented healthcare system.

    Profil von Thomas Gläser 🚀 anzeigen, Grafik

    AI-Driven Product Leader | From Idea to Go-to-Market

    💬 𝐃𝐞𝐚𝐫 𝐍𝐞𝐭𝐰𝐨𝐫𝐤, 𝐈 𝐧𝐞𝐞𝐝 𝐲𝐨𝐮𝐫 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 💬 Are you living with a 𝐜𝐡𝐫𝐨𝐧𝐢𝐜 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐨𝐧𝐝𝐢𝐭𝐢𝐨𝐧, or do you know someone who is? I'm currently conducting a survey for the Health-Tech Startup dehaze to gather insights that will shape the next level of their App. Your input can make a real difference! 👉 𝐓𝐚𝐤𝐞 𝐭𝐡𝐞 𝐒𝐮𝐫𝐯𝐞𝐲 𝐢𝐧 🇩🇪 𝐨𝐫 🇬🇧 𝐇𝐞𝐫𝐞: https://lnkd.in/dGFPWk9Y I'm currently supporting dehaze with my product expertise as we develop an app aimed at improving the lives of those with chronic conditions by offering: 🗄️ 𝐂𝐞𝐧𝐭𝐫𝐚𝐥𝐢𝐳𝐞𝐝 𝐇𝐞𝐚𝐥𝐭𝐡 𝐃𝐚𝐭𝐚: Keep all your health records in one secure place. 🧑⚕️ 𝐂𝐨𝐧𝐭𝐫𝐨𝐥 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐘𝐨𝐮𝐫 𝐃𝐚𝐭𝐚: Easily manage who can access your data, from doctors to family members. 💡 𝐏𝐫𝐨𝐯𝐢𝐝𝐞 𝐌𝐞𝐚𝐧𝐢𝐧𝐠𝐟𝐮𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Get personalized analysis to better understand your condition and treatment. 📈 𝐄𝐦𝐩𝐨𝐰𝐞𝐫 𝐰𝐢𝐭𝐡 𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞: Receive tailored recommendations to take control of your health. 🤝 𝐂𝐨𝐧𝐧𝐞𝐜𝐭 𝐰𝐢𝐭𝐡 𝐎𝐭𝐡𝐞𝐫𝐬: Chat with patients, health experts, and solution providers for support and advice. We’ve already seen great results with MS patients and their doctors, and now we’re ready to expand! 💡 𝐘𝐨𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐌𝐚𝐭𝐭𝐞𝐫𝐬: Whether you have a chronic condition like diabetes, arthritis, or asthma, or you’re connected to someone who does, your feedback will be invaluable. Please take 20 minutes to help us build something truly impactful. Thank you for being a part of this journey toward better health management! 🙏 #HealthTech #ChronicIllness #ChronicDisease #PatientCare #DigitalHealth #HealthcareInnovation

    • dehaze Survey – Top Features for Chronic Conditions
  • Unternehmensseite von dehaze anzeigen, Grafik

    252 Follower:innen

    dehaze is growing! We are looking for a clinical lead (m/f/d) to join our journey to bring precision medicine to the patient starting with neurodegenerative diseases. #healthcare #precisionmedicine #recruiting #neurology

    Unternehmensseite von Techstars Berlin anzeigen, Grafik

    5.042 Follower:innen

    𝑹𝒆𝒂𝒅𝒚 𝒕𝒐 𝒅𝒊𝒗𝒆 𝒊𝒏𝒕𝒐 𝒂 𝒘𝒐𝒓𝒍𝒅 𝒐𝒇 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏, 𝒇𝒂𝒔𝒕 𝒈𝒓𝒐𝒘𝒕𝒉, 𝒂𝒏𝒅 𝒊𝒎𝒑𝒂𝒄𝒕? 💥 𝒀𝒐𝒖𝒓 𝒋𝒐𝒖𝒓𝒏𝒆𝒚 𝒔𝒕𝒂𝒓𝒕𝒔 𝒉𝒆𝒓𝒆! 🌍🔝 dehaze is currently looking for a 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐋𝐞𝐚𝐝 (𝐦/𝐰/𝐝) that will: → Establish and manage partnerships with clinicians → Analyse and translate Multiple Sclerosis (MS) research into actionable insights → Manage clinical partnerships with customers (i.e. pharmaceutical companies) dehaze is a Techstars Berlin company on a mission to become the No.1 treatment efficacy predictor for neurodegenerative diseases. Co-founded by Marius Klages, Julian Matschinske, and Jan Baumbach, the team is dedicated to delivering precision medicine directly to patients. Their innovative approach enables the prediction of treatment effectiveness and disease progression for individual patients, ultimately enhancing their quality of life. The initial focus is on helping individuals with MS. If you’re interested, send your CV to marius@dehaze.de or reach out to Marius Klages on LinkedIn! Additional details about the role can be found here: https://lnkd.in/g2GgE_sa Tag someone below who you think would be a great fit for this position. 👀👇

Ähnliche Seiten

Finanzierung

dehaze Insgesamt 1 Finanzierungsrunde

Letzte Runde

Pre-Seed

20.000,00 $

Investor:innen

Techstars
Weitere Informationen auf Crunchbase